Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Miller-Rhodes

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Matters|May 10, 2021
The Cell Culture Environment Regulates the Transcription Factor MafB in BV-2 MicrogliaPatrick Miller-Rhodes, Harris A Gelbard
Trends in Neurosciences|September 21, 2020
This Is Your Brain on (Low) GlucosePatrick Miller-Rhodes, Harris A Gelbard, Niccolò Terrando
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 10, 2022
URMC-099 prophylaxis prevents hippocampal vascular vulnerability and synaptic damage in an orthopedic model of delirium superimposed on dementiaPatrick Miller-Rhodes, Herman Li, Ravikanth Velagapudi, et al.
Neurotoxicology and Teratology|July 5, 2014
Prenatal exposure to the brominated flame retardant hexabromocyclododecane (HBCD) impairs measures of sustained attention and increases age-related morbidity in the Long-Evans ratPatrick Miller-Rhodes, Maria Popescu, Calla Goeke, et al.
Neurotoxicology and Teratology|November 26, 2021
Sex-specific behavioral impairments produced by neonatal exposure to MK-801 are partially reversed by adolescent CDPPB treatmentPatrick Miller-Rhodes, Nadine Piazza, Anna Mattle, et al.
Neurotoxicology and Teratology|August 3, 2017
Motor deficits, impaired response inhibition, and blunted response to methylphenidate following neonatal exposure to decabromodiphenyl etherVincent P Markowski, Patrick Miller-Rhodes, Randy Cheung, et al.
Journal of Neuroinflammation|October 30, 2019
The broad spectrum mixed-lineage kinase 3 inhibitor URMC-099 prevents acute microgliosis and cognitive decline in a mouse model of perioperative neurocognitive disordersPatrick Miller-Rhodes, Cuicui Kong, Gurpreet S Baht, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 3, 2015
Leucine-rich repeat kinase 2 modulates neuroinflammation and neurotoxicity in models of human immunodeficiency virus 1-associated neurocognitive disordersJenna M Puccini, Daniel F Marker, Tim Fitzgerald, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Matters|May 10, 2021
The Cell Culture Environment Regulates the Transcription Factor MafB in BV-2 MicrogliaPatrick Miller-Rhodes, Harris A Gelbard
Trends in Neurosciences|September 21, 2020
This Is Your Brain on (Low) GlucosePatrick Miller-Rhodes, Harris A Gelbard, Niccolò Terrando
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 10, 2022
URMC-099 prophylaxis prevents hippocampal vascular vulnerability and synaptic damage in an orthopedic model of delirium superimposed on dementiaPatrick Miller-Rhodes, Herman Li, Ravikanth Velagapudi, et al.
Neurotoxicology and Teratology|July 5, 2014
Prenatal exposure to the brominated flame retardant hexabromocyclododecane (HBCD) impairs measures of sustained attention and increases age-related morbidity in the Long-Evans ratPatrick Miller-Rhodes, Maria Popescu, Calla Goeke, et al.
Neurotoxicology and Teratology|November 26, 2021
Sex-specific behavioral impairments produced by neonatal exposure to MK-801 are partially reversed by adolescent CDPPB treatmentPatrick Miller-Rhodes, Nadine Piazza, Anna Mattle, et al.
Neurotoxicology and Teratology|August 3, 2017
Motor deficits, impaired response inhibition, and blunted response to methylphenidate following neonatal exposure to decabromodiphenyl etherVincent P Markowski, Patrick Miller-Rhodes, Randy Cheung, et al.
Journal of Neuroinflammation|October 30, 2019
The broad spectrum mixed-lineage kinase 3 inhibitor URMC-099 prevents acute microgliosis and cognitive decline in a mouse model of perioperative neurocognitive disordersPatrick Miller-Rhodes, Cuicui Kong, Gurpreet S Baht, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 3, 2015
Leucine-rich repeat kinase 2 modulates neuroinflammation and neurotoxicity in models of human immunodeficiency virus 1-associated neurocognitive disordersJenna M Puccini, Daniel F Marker, Tim Fitzgerald, et al.
Pageof 1